EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis

Natsuki Yamaguchi, Eri Horio, Jukito Sonoda, Miu Yamagishi, Satomi Miyakawa, Fumihiro Murakami, Hideaki Hasegawa, Yasuhiro Katahira iD, Izuru Mizoguchi, Yasuyuki Fujii iD, Daichi Chikazu, Takayuki Yoshimoto iD

International Journal of Molecular Sciences · 18.12.2024 · 25 (24) · 13562

DOI: 10.3390/ijms252413562 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.12.2024. Verfasst von Natsuki Yamaguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Regenerative Medicine, Carcinogenesis. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Ministry of Education, Culture, Sports, Science and Technology, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regenerative medicine utilizes stem cells to repair damaged tissues by replacing them with their differentiated cells and activating the body’s inherent regenerative abilities. Mesenchymal stem cells (MSCs) are adult stem cells that possess tissue repair and regenerative capabilities and immunomodulatory properties with a much lower risk of tumorigenicity, making them a focus of numerous clinical trials worldwide. MSCs primarily exert their therapeutic effects through paracrine effects via secreted factors, such as cytokines and exosomes. This has led to increasing interest in cell-free therapy, where only the conditioned medium (also called secretome) from MSC cultures is used for regenerative applications. However, MSCs face certain limitations, including cellular senescence, scarcity, donor heterogeneity, complexity, short survival post-implantation, and regulatory and ethics hurdles. To address these challenges, various types of immortalized MSCs (ImMSCs) capable of indefinite expansion have been developed. These cells offer significant promise and essential tools as a reliable source for both cell-based and cell-free therapies with the aim of translating them into practical medicine. However, the process of immortalization, often involving the transduction of immortalizing genes, poses potential risks of genetic instability and resultant malignant transformation. Cell-free therapy is particularly attractive, as it circumvents the risks of tumorigenicity and ethical concerns associated with live cell therapies. Rigorous safety tests, such as monitoring chromosomal abnormalities, are critical to ensure safety. Technologies like inducible or suicide genes may allow for the controlled proliferation of MSCs and induce apoptosis after their therapeutic task is completed. This review highlights recent advancements in the immortalization of MSCs and the associated risks of tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsRegenerative MedicineCarcinogenesisHumansAnimalsCell Transformation, NeoplasticMesenchymal Stem Cell Transplantation

Stichwörter der Autor:innen

cell-based therapycell-free therapyimmortalizationmesenchymal stem cellsregenerative medicinetumorigenesis

Autor:innen und Institutionen

  • Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
  • Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.

ORCID-Profile: Yasuhiro Katahira, Yasuyuki Fujii, Takayuki Yoshimoto

Förderung

  • Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan
  • Ministry of Education, Culture, Sports, Science and Technology, Japan

Zitieren

APA

Yamaguchi, N., Horio, E., Sonoda, J., Yamagishi, M., Miyakawa, S., Murakami, F., Hasegawa, H., Katahira, Y., Mizoguchi, I., Fujii, Y., Chikazu, D., & Yoshimoto, T. (2024). Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis. International Journal of Molecular Sciences, 25(24), 13562. https://doi.org/10.3390/ijms252413562

Vancouver

Yamaguchi N, Horio E, Sonoda J, Yamagishi M, Miyakawa S, Murakami F, et al. Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis. International Journal of Molecular Sciences. 2024;25(24):13562. doi:10.3390/ijms252413562

BibTeX
@article{Yamaguchi2024,
  author = {Yamaguchi, Natsuki and Horio, Eri and Sonoda, Jukito and Yamagishi, Miu and Miyakawa, Satomi and Murakami, Fumihiro and Hasegawa, Hideaki and Katahira, Yasuhiro and Mizoguchi, Izuru and Fujii, Yasuyuki and Chikazu, Daichi and Yoshimoto, Takayuki},
  title = {Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {24},
  pages = {13562},
  doi = {10.3390/ijms252413562}
}
Kostenlos starten →